Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs

Affiliations

• ¹ The Kirby Institute, UNSW Sydney, Sydney, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
• ² Brown University School of Public Health, Providence, RI, United States.
• ³ Population Health Sciences, Bristol Medical School, University of Bristol, United Kingdom.
• ⁴ National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
• ⁵ AIDS Program, Yale School of Medicine, New Haven, United States; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, United States.
• ⁶ Divisions of General Internal Medicine and Infectious Diseases, University of Colorado School of Medicine, Aurora, United States.
• ⁷ Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, United States.
• ⁸ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,Baltimore, United States.
• ⁹ The Kirby Institute, UNSW Sydney, Sydney, Australia.
• ¹⁰ The Kirby Institute, UNSW Sydney, Sydney, Australia; Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.
• ¹¹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
• ¹² Canadian Association of People Who Use Drugs, Dartmouth, Canada.
• ¹³ Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.